Search Results 921-930 of 18586 for Relapse
Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma featured. Cancer. Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin ...
... Relapsed Or Refractory Chronic Lymphocytic Leukemia. Rochester, Minn. This study will assess the safety, tolerability, pharmaokinetics, and preliminary ...
MRD detection from proximal biofluids to anticipate cancer relapse. Oligometastatic cancer risk stratification. Precision oncology. More about research at ...
It is also used together with dexamethasone to treat multiple myeloma that has come back (relapsed) or has not responded to treatment (refractory) in ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...
Treatment typically focuses on speeding recovery from attacks, managing symptoms and reducing relapses. You meet with your healthcare team to come up with a ...
... relapse immediately prior to the transplant;; If disease relapse prior to transplant and the patient did have treatment for the relapsed disease prior to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.